CSIMarket Company Name, Ticker, Customers, else..
 
Guided Therapeutics Inc   (GTHP)
Other Ticker:  
 
 
Price: $0.1730 $0.00 -1.143%
Day's High: $0.1725 Week Perf: 1.17 %
Day's Low: $ 0.17 30 Day Perf: 8.12 %
Volume (M): 7 52 Wk High: $ 0.23
Volume (M$): $ 1 52 Wk Avg: $0.14
Open: $0.17 52 Wk Low: $0.06



 Market Capitalization (Millions $) 10
 Shares Outstanding (Millions) 57
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Guided Therapeutics Inc
Guided Therapeutics Inc is a medical device company that specializes in the development and commercialization of non-invasive diagnostic devices. The company's flagship product is the LuViva Advanced Cervical Scan, which is designed to detect cervical disease and precancerous conditions in women.

Guided Therapeutics' LuViva technology utilizes a non-invasive method that combines spectroscopy and advanced optics to provide immediate results and improve the accuracy of cervical disease detection. The device can distinguish between normal and abnormal cervical tissue, enabling healthcare providers to make timely and educated decisions regarding patient care.

The company is dedicated to improving women's health and reducing the number of unnecessary biopsies and procedures associated with cervical disease. By providing a non-invasive, quick, and accurate diagnostic solution, Guided Therapeutics aims to transform the way cervical disease is detected and managed.

Guided Therapeutics Inc has received regulatory approvals for its product in various countries and continues to expand its commercial reach globally. The company also actively engages in research and development to enhance its existing technology and explore new applications in the field of non-invasive diagnostics.


   Company Address: 5835 Peachtree Corners East Peachtree Corners 30092 GA
   Company Phone Number: 242-8723   Stock Exchange / Ticker: GTHP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX        1.2% 
BSX        1.63% 
CUTR   -8.16%    
ESTA        5.73% 
MDT   -1.74%    
OSUR   -0.75%    
• View Complete Report
   



Business Update

Guided Therapeutics Eyes New Markets Amid Ongoing Financial Challenges,

Published Tue, Dec 10 2024 5:47 PM UTC

In a significant strategic move, Guided Therapeutics, Inc., the developer of the LuViva Advanced Cervical Scan, has secured a major order from an Indonesian distribution partner, marking a pivotal moment for the company. The order includes four LuViva devices along with 1,200 single-use disposables, which are set to be delivered in the first quarter of 2025. This initial shi...
Guided Therapeutics Inc

Guided Therapeutics Inc Shows Resilience and Progress Amid Financial Challenges

Guided Therapeutics Inc Faces Challenges But Remains on a Positive Trajectory
Despite facing some setbacks during the January to March 31, 2024 financial span, Guided Therapeutics Inc is demonstrating resilience and strategic adaptability. The company reported a loss of $-0.01 per share, an improvement from the previous year's loss of $-0.02 per share, highlighting the progress made in managing costs and optimizing operations. Furthermore, the revenue declined by -72.727% to $0.01 million from $0.02 million in the same reporting season a year prior.
Despite the challenging financials, Guided Therapeutics Inc managed to decrease its net deficit to $-0.402 million compared to $-0.934 million in the same reporting season a year ago. This impressive reduction in net deficit exhibits the company's commitment to improving its financial health and creating value for its shareholders.
Guided Therapeutics Inc

Guided Therapeutics Inc Shows Strong Financial Improvement in 2023 Fourth Quarter2.

Guided Therapeutics Inc is a medical equipment and supplies company that has shown significant improvements in its financial performance in the recent fiscal period from October to December 31, 2023. Despite the seasonal nature of the business, the company reported a revenue of $0.032 million during this time frame, which represents a positive growth trajectory compared to the previous year. Additionally, the company managed to reduce its net loss to $-0.420 million, a substantial improvement from the deficit of $-1.354 million recorded in the same period a year ago.
One of the notable highlights from Guided Therapeutics Inc's financial report is the decrease in inventories to $0.6 million, indicating an efficient management of resources. This decline in inventory levels also marks an increase relative to the same period a year ago, reflecting the company's efforts to optimize its operations and streamline its supply chain.
Guided Therapeutics Inc

Remarkable Transformation: Company's Evanescence of Losses Turns Heads in July-September 2023 Span!

An Encouraging Quarter for Guided Therapeutics Inc in the Stock Market
Guided Therapeutics Inc, a prominent player in the medical device industry, recently released its financial results for the quarter ending September 30, 2023. The company's performance showed significant improvements, which have been well-received by investors. Let's dive into the key highlights and understand the implications for the stock market.
One of the most striking elements in Guided Therapeutics Inc's report is the decrease in the loss per share compared to both the previous year and the preceding quarter. For the July to September 2023 span, the company reduced its loss per share to $-0.01, a significant improvement from $-0.03 a year ago. This reduction indicates that the company is on an upward trajectory and is successfully working towards improving its financials.
Guided Therapeutics Inc

Guided Therapeutics Inc Achieves Impressive Revenue Growth in Q2 2023 Despite Net Losses

Guided Therapeutics Inc Reports Strong Revenue Growth in Second Quarter of 2023 Despite Losses
Guided Therapeutics Inc, a medical equipment and supplies company, recently announced a significant increase in revenue for the second quarter of 2023. The company reported a robust revenue advance of 780% year on year, reaching $0.04 million. However, Guided Therapeutics Inc also experienced a net loss of $-0.03 million during the same period.
While the company's revenue growth outpaced that of its peers in the Medical Equipment & Supplies industry, with most companies in the sector recording an average top-line advance of 4.48%, Guided Therapeutics Inc faced a financial setback in terms of net profit. The company's deficit per share increased from $-0.02 in the previous quarter to $-0.03, and revenue surged by 100% from $0.02 million.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com